Prelude Therapeutics
PRLD
PRLD
57 hedge funds and large institutions have $986M invested in Prelude Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
30% less capital invested
Capital invested by funds: $1.41B → $986M (-$423M)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$23M | |
| 2 | +$14.2M | |
| 3 | +$10.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.21M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.37M |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$1.27M | |
| 3 | -$886K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$845K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$790K |